About
Developing bio-interventional treatments for glaucoma (procedural alternatives to MIGS). Raised $42M to fund the US launch.
HQ: US
Funding
$42M round (2025)
—Company profile
Bio-interventional glaucoma — AlloFlo Uveo / AlloSpan with a $42M raise for launch.
Developing bio-interventional treatments for glaucoma (procedural alternatives to MIGS). Raised $42M to fund the US launch.
HQ: US